Literature DB >> 7490362

Lentigo maligna and lentigo maligna melanoma.

L M Cohen1.   

Abstract

Lentigo maligna (LM) is a pigmented lesion that occurs on the sun-exposed skin, particularly the head and neck areas, of an older patient. The lesion increases in size and at some point, often many years after its onset, may become lentigo maligna melanoma (LMM). For this reason, most authors consider LM a form of melanoma in situ. Treatment includes surgical or destructive modalities; the preferred form of therapy is surgical removal. Histopathologic features include a proliferation of atypical melanocytes along the basal layer of the epidermis and adnexal structures. This article discusses the clinical, histopathologic, and epidemiologic features of LM. The prognosis and treatment of LM are reviewed. Although the lifetime risk of the development of LMM is unclear, LMM is discussed briefly.

Entities:  

Mesh:

Year:  1995        PMID: 7490362     DOI: 10.1016/0190-9622(95)90282-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  22 in total

1.  Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.

Authors:  Erin X Wei; Abrar A Qureshi; Jiali Han; Tricia Y Li; Eunyoung Cho; Jennifer Y Lin; Wen-Qing Li
Journal:  J Am Acad Dermatol       Date:  2016-07-16       Impact factor: 11.527

2.  Naevus-associated lentigo maligna: coincidence or continuum?

Authors:  A Lallas; I Zalaudek; C Cota; E Moscarella; D Tiodorovic-Zivkovic; C Catricalà; G Argenziano
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

3.  The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type.

Authors:  Elke Stadelmeyer; Ellen Heitzer; Margit Resel; Lorenzo Cerroni; Peter Wolf; Nadia Dandachi
Journal:  J Invest Dermatol       Date:  2013-08-09       Impact factor: 8.551

Review 4.  Surgical Management of Periocular Cancers: High- and Low-Risk Features Drive Treatment.

Authors:  Richard C Allen
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

5.  An extrafacial amelanotic lentigo maligna of the leg: a case report.

Authors:  Antonella Tammaro; Diego Orsini; Alessandra Narcisi; Giorgia Cortesi; Francesca R Parisella; Veronica Giulianelli; Claudia Abruzzese; Severino Persechino
Journal:  Int Wound J       Date:  2014-08-14       Impact factor: 3.315

6.  Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort.

Authors:  Sungshim Lani Park; Loïc Le Marchand; Lynne R Wilkens; Laurence N Kolonel; Brian E Henderson; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-13

Review 7.  Emerging strategies to treat rare and intractable subtypes of melanoma.

Authors:  Gretchen M Alicea; Vito W Rebecca
Journal:  Pigment Cell Melanoma Res       Date:  2020-04-24       Impact factor: 4.693

8.  Variant on Manifestation of Duodenal Metastasis 26 Years after Initial Diagnosis of Primary Cutaneous Melanoma.

Authors:  Kumiko Kitajima; Armelle Bardier-Dupas; Sylvie Breton; Géraldine Rousseau; Jean-Michel Siksik; Jean-Christophe Vaillant; Laurent Hannoun
Journal:  Case Rep Gastroenterol       Date:  2010-03-17

9.  From melanocyte to metastatic malignant melanoma.

Authors:  Bizhan Bandarchi; Linglei Ma; Roya Navab; Arun Seth; Golnar Rasty
Journal:  Dermatol Res Pract       Date:  2010-08-11

10.  Cutaneous melanoma: hints from occupational risks by anatomic site in Swedish men.

Authors:  B Perez-Gomez; M Pollán; P Gustavsson; N Plato; N Aragonés; G López-Abente
Journal:  Occup Environ Med       Date:  2004-02       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.